The Editor’s Roundtable: Atherosclerosis Regression

  • Vincent E. Friedewald
    Corresponding author: Tel: 512-264-1611; fax: 512-264-7034.
    Assistant Editor, American Journal of Cardiology, Clinical Professor, Department of Internal Medicine, The University of Texas Medical School at Houston, Houston, Texas USA, and Research Professor, College of Science, University of Notre Dame, Notre Dame, Indiana
    Search for articles by this author
  • Christie M. Ballantyne
    Director, Center for Cardiovascular Disease Prevention, Methodist DeBakey Heart Center, Chief, Section of Atherosclerosis and Vascular Medicine, Department of Medicine, Baylor College of Medicine, Director, Maria and Alando J. Ballantyne, MD, Atherosclerosis Laboratory, Professor of Medicine, Joint Appointment in Pediatrics, Baylor College of Medicine, and Co-Director, Lipid Metabolism and Atherosclerosis Clinic, The Methodist Hospital, Houston, Texas
    Search for articles by this author
  • Steven E. Nissen
    Chairman, Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio
    Search for articles by this author
  • P.K. Shah
    Shapell and Webb Chair and Director, Division of Cardiology and Atherosclerosis Research Center, Cedars Sinai Medical Center, and Professor of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California
    Search for articles by this author
  • William C. Roberts
    Editor-in-Chief, American Journal of Cardiology and Baylor University Medical Center Proceedings, Executive Director, Baylor Heart and Vascular Institute, Baylor University Medical Center, and Dean, A. Webb Roberts Center for CME of Baylor Health Care System, Dallas, Texas.
    Search for articles by this author
      This CME activity is sponsored by an educational grant from AstraZeneca, Wilmington, Delaware.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Nissen S.E.
        • Tuzcu E.M.
        • Schoenhagen P.
        • Brown B.G.
        • Ganz P.
        • Vogel R.A.
        • Crowe T.
        • Howard G.
        • Cooper C.J.
        • Brodie B.
        • et al.
        Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial.
        JAMA. 2004; 291: 1071-1080
        • Nissen S.E.
        • Nicholls S.J.
        • Sipahi I.
        • Libby P.
        • Raichlen J.S.
        • Ballantyne C.M.
        • Davignon J.
        • Erbel R.
        • Fruchart J.C.
        • et al.
        • ASTEROID Investigators
        Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial.
        JAMA. 2006; 295: 1556-1565
        • Nicholls S.J.
        • Tuzcu E.M.
        • Grasso A.W.
        • Schoenhagen P.
        • Hu T.
        • Wolski K.
        • Crowe T.
        • Desai M.Y.
        • Hazen S.L.
        • Kapadia S.R.
        • Nissen S.E.
        Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis.
        JAMA. 2007; 297: 499-508
        • Klein L.W.
        Atherosclerosis regression, vascular remodeling, and plaque stabilization.
        J Am Coll Cardiol. 2007; 49: 271-273
        • Nissen S.E.
        • Tsunoda T.
        • Tuzcu E.M.
        • Schoenhagen P.
        • Cooper C.J.
        • Yasin M.
        • Eaton G.M.
        • Lauer M.A.
        • Sheldon W.S.
        • Grines C.L.
        • et al.
        Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial.
        JAMA. 2003; 290: 2292-2300
        • Shah P.K.
        Mechanisms of plaque vulnerability and rupture.
        J Am Coll Cardiol. 2003; 41: 15S-22S
        • Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
        Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III).
        JAMA. 2001; 285: 2486-2497
        • Cohen J.C.
        • Boerwinkle E.
        • Mosley T.H.
        • Hobbs H.H.
        Sequence variations in PCSK9, low LDL, and protection against coronary heart disease.
        N Engl J Med. 2006; 354: 1264-1272
        • Nissen S.E.
        • Tuzcu E.M.
        • Libby P.
        • Thompson P.D.
        • Ghali M.
        • Garza D.
        • Berman L.
        • Shi H.
        • Buebendorf E.
        • Topol E.J.
        • CAMELOT Investigators
        Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure.
        JAMA. 2004; 292: 2217-2225